All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the MDS Alliance
To help navigate the exciting content being presented at the EHA2021 Virtual Congress, the MDS Hub Steering Committee members have provided their recommendations for the top abstracts to look out for in MDS.
EHA2021 abstracts: what’s hot in myelodysplastic syndromes?
If you would like to view the top abstracts to look out for in myelodysplastic syndromes at EHA2021, please download the resource below.Download here
Why is TIM-3 a good target for treating patients with high-risk MDS?
During the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, the MDS Hub spoke to Andrew M. Brunner, Massachusetts General Hospital, Boston, US. We asked, Why...
Should the telomerase inhibitor imetelstat become SoC in transfusion-dependent low-risk MDS?
During the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, the MDS Hub spoke to Uwe Platzbecker, University of Leipzig Medical...
Subscribe to get the best content related to MDS delivered to your inbox